Published on Wednesday, August 30, 2017 Print
George Reynolds, Vitro's Chief Commercial Officer - Europe and Rare Disease expert, is chairing an interactive roundtable on November 15th at 11.20 "Linking registries and clinical trials through ERNs: The paradigm shift in meeting Marketing Authorisation requirements". For more information visit www.terrapinn.com/conference/world-orphan-drug-congress/agenda.stm
EUROPE’S MEETING PLACE FOR THE RARE DISEASE COMMUNITY. The 8th annual World Orphan Drug Congress is the marketplace for orphan drug professionals looking at the complete value chain of orphan drug development, from clinical development and R&D to corporate development and market access.
Author: Vitro Software
Categories: News, Ireland & Europe, Events
Tags: Conference Speaker, Conference